ViroPharma, Inc. (NASDAQ:VPHM)

CAPS Rating: 4 out of 5

A biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings.

Results 1 - 20 of 167 : 1 2 3 4 5 6 7 8 9 Next »

Recs

0
Member Avatar IfHeDiesHeDies (47.36) Submitted: 3/8/2013 7:41:48 PM : Outperform Start Price: $26.48 VPHM Score: +1.64

A-.4 Star.

Recs

0
Member Avatar tbonci (78.39) Submitted: 1/13/2013 8:43:00 AM : Underperform Start Price: $24.69 VPHM Score: -3.37

Poor sales growth, high volatility.

Recs

1
Member Avatar zzlangerhans (99.75) Submitted: 11/7/2012 11:31:39 PM : Outperform Start Price: $24.80 VPHM Score: -2.69

Nothing much to see here except some correction green thumbing. ViroPharma is getting dragged down along with most other biopharma mid caps despite the impressive growth in Cinryze sales. Vancocin revenues are shrinking to nothing but that was expected once the generic serpent hatched. The share price bottomed at 20 after the bad news broke about generics and then rose over 30 at the height of September's biopharma fever. The stock may well be headed back to 20 if broad market weakness continues, but at some point the winds will shift again.

Recs

0
Member Avatar portefeuille (99.75) Submitted: 4/10/2012 7:48:41 PM : Outperform Start Price: $22.72 VPHM Score: +4.47

There are currently 200 VPHM shares in my fund with break-even of around -2.79 USD.

http://caps.fool.com/Blogs/fund-trades/725331.
http://twitter.com/portefeuillefun.

Recs

1
Member Avatar yesand (26.04) Submitted: 7/29/2011 2:48:48 PM : Outperform Start Price: $18.07 VPHM Score: +31.26

Good pharma in pipeline

Recs

1
Member Avatar jeffrycooks (70.45) Submitted: 4/28/2011 10:35:39 PM : Outperform Start Price: $9.25 VPHM Score: +179.11

This one is looking good 4/28/11 may consider this on a good pullback. Like chart, statements, etc...

Recs

0
Member Avatar RazorSphinx (< 20) Submitted: 4/28/2011 7:34:29 AM : Outperform Start Price: $20.56 VPHM Score: +17.17

Magic Formula

Recs

0
Member Avatar NicolasDarvas (21.74) Submitted: 1/8/2011 9:23:39 PM : Outperform Start Price: $17.45 VPHM Score: +33.48

stockmillionare.

Recs

0
Member Avatar Hotpicks101 (29.73) Submitted: 1/6/2011 12:27:10 PM : Underperform Start Price: $17.68 VPHM Score: -31.97

zz and ultra.

Recs

0
Member Avatar onzelot (< 20) Submitted: 10/27/2010 4:06:23 PM : Outperform Start Price: $16.72 VPHM Score: +32.39

Brings their the product to the rest of the world

Recs

0
Member Avatar andrepaws (< 20) Submitted: 9/24/2010 8:14:50 PM : Outperform Start Price: $15.12 VPHM Score: +45.46

any companythat can get seniors to pay 5,000 for meds to clear up hospital infection that medicare
will not cover is already a moneymaker!

Recs

0
Member Avatar seekdelta (< 20) Submitted: 8/30/2010 8:44:26 PM : Outperform Start Price: $12.61 VPHM Score: +69.55

As per this article: http://seekingalpha.com/article/220613-viropharma-a-tale-of-two-drugs?source=TheMotleyFool

Recs

0
Member Avatar LuckyShad (52.17) Submitted: 8/18/2010 1:38:55 PM : Outperform Start Price: $13.54 VPHM Score: +61.50

CAPS=5/88

Recs

0
Member Avatar 20100626 (< 20) Submitted: 7/17/2010 12:32:40 PM : Outperform Start Price: $10.91 VPHM Score: +108.15

Bravobevo

Recs

0
Member Avatar cashsage (29.98) Submitted: 12/9/2009 12:26:04 PM : Underperform Start Price: $7.63 VPHM Score: -224.66

VPHM has a too high valuation compared to its sales potential. It is also loss making.

Recs

0
Member Avatar bajamar (< 20) Submitted: 11/9/2009 3:37:40 AM : Outperform Start Price: $7.68 VPHM Score: +220.04

will be trading in 9to10 range in three weeks

Recs

0
Member Avatar spundun (25.92) Submitted: 10/9/2009 3:26:22 PM : Outperform Start Price: $9.85 VPHM Score: +136.49

UL's rec

Recs

0
Member Avatar lukylex (50.95) Submitted: 9/28/2009 11:37:59 AM : Outperform Start Price: $9.78 VPHM Score: +137.41

Short term holding till $13

Recs

0
Member Avatar jmc268 (< 20) Submitted: 9/18/2009 9:06:56 PM : Outperform Start Price: $8.28 VPHM Score: +189.98

Making great profits and increasing them year to year, 5.55 P/E today, I like it

Recs

0
Member Avatar aordinaryguy (68.16) Submitted: 9/11/2009 6:16:53 PM : Outperform Start Price: $4.88 VPHM Score: +384.12

I've been watching this stock for quite awhile and it finally hit my entry point. With this type of PE, for a biopharma, I see GOOD things, LONG term for this company.

Featured Broker Partners


Advertisement